09:15 uur 13-06-2018

NeuroInDx, Inc. lanceert UNIPICK+™ en universele eencellige tissue microdissection instrument

TORRANCE, Calif.–(BUSINESS WIRE)–

NeuroInDx, Inc. lanceert UNIPICK+™ en een nieuwe toepassing, breidt uit met het UNIPICK™-systeem voor cel- en weefselacquisitie.

NeuroInDx, Inc. (NDX) kondigt met trots de release aan van de nieuwste versie van het NDX Cell & Tissue Acquisition System, UNIPICK+™.

Dit persbericht is multimediaal. Bekijk de volledige versie hier: https://www.businesswire.com/news/home/20180612005054/en/

NeuroInDx, Inc. Launches UNIPICK+™ – Adding New Capabilities to the Universal Single Cell Collection and Tissue Microdissection Instrument

TORRANCE, Calif.–(BUSINESS WIRE)–

NeuroInDx, Inc. Launches UNIPICK+ and a New Application, Expands on UNIPICK Cell and Tissue Acquisition System

NeuroInDx, Inc. (NDX) is proud to announce the release of the latest version of the NDX Cell & Tissue Acquisition System, UNIPICK+™.

UNIPICK+™ is het nieuwste lid van de Cell & Tissue Acquisition System (CTAS) familie van producten gebouwd op gepatenteerde capillaire vacuüm ondersteunde technologie ontworpen bij UCLA en ontwikkeld door NDX voor de isolatie van individuele cellen van culturen en weefsel microdissectie. Het systeem maakt gebruik van een propriëtair straddle om de meeste in de handel verkrijgbare omgekeerde microscopen te passen, waardoor onderzoekers mogelijkheden voor isolatie met één cel kunnen toevoegen aan hun labbank tegen een fractie van de prijs van conventionele systemen.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180612005054/en/

Automated UNIPICK+™ directly integrated with Olympus IX73 inverted microscope (Photo: Business Wire)

Automated UNIPICK+™ directly integrated with Olympus IX73 inverted microscope (Photo: Business Wire)

UNIPICK+™ is the latest member of the Cell & Tissue Acquisition System (CTAS) family of products built on patented capillary-based vacuum assisted technology conceived at UCLA and developed by NDX for the isolation of individual cells from cultures and tissue microdissection. The system uses a proprietary straddle to fit most commercially available inverted microscopes, allowing researchers to add single cell isolation capabilities to their lab bench at a fraction of the price of conventional systems.

The instrument can isolate cells from a variety of formats, including tissue sections, adherent cultures, cell suspensions, 3D cultures, smears, and microfluidic chips. UNIPICK+™ features new design, full digital control, and an optional automation. Among the new applications is a novel single cell adhesion assay for comparative measurements of binding strengths among various cell types or substrates. This capability expands UNIPICK+™ application from sample acquisition to single cell analysis.

UNIPICK+™ brings new automated features while remaining the simplest and most cost-efficient solution for single cell isolation and tissue microdissection. It is available as a free-standing unit that may be used with most inverted microscopes or may be directly integrated with Olympus IX73/83 microscopes. Researchers can simply use UNIPICK+™ when they need to isolate cells and then revert to their microscope for routine cell and tissue work. It only takes a few minutes to set up the system and no microscope modifications are required.

“UNIPICK+™ enhances our product line of the most versatile and cost-efficient tools for cell isolation and tissue microdissection. By designing our instruments to be compatible with common inverted microscopes, we continue to bring value added products at a fraction of the cost of other more expensive systems,” said Stan Karsten, PhD, NDX President and CEO.

About NeuroInDx, Inc.

NeuroInDx, Inc. (NDX), founded in 2006, develops instruments for cell collection and tissue microdissection for a wide range of applications in biological sciences. For more information, please visit www.NeuroInDx.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20180612005054/en/

Contacts

NeuroInDx, Inc.
Stan Karsten, PhD, 424-731-7512
President and CEO
info@neuroindx.com

Check out our twitter: @NewsNovumpr